Clinical trial
Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss…
NCT00164008 · Bayside Health, Other · Completed
Key facts
| NCT number | NCT00164008 |
|---|---|
| Title | Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention |
| Official title | Comparison Between Pamidronate and Zoledronic Acid for the Treatment of Heart and Lung Transplant Related Osteopaenia and Osteoporosis |
| Lead sponsor | Bayside Health, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteopenia, Complications of Heart-lung Transplant, Other Complications of Lung Transplant |
| Intervention type | Drug |
| Interventions | zoledronic acid vs pamidronate |
| Enrollment | 56 |
| Start date | Oct 1, 2002 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | Dec 5, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: